|
Complainant part is not expected to be returned for manufacturer review/investigation.This mre review is for sterilization procedure only part: 04.034.588s, lot: 7488853, manufacturing site: (b)(4), supplier: (b)(6), release to warehouse date: 16.October 2013, expiry date: 01.October 2023.A manufacturing record evaluation was performed for the finished device lot number, and no non-conformances were identified.Non-sterile 04.034.588 / 7488601 was manufactured in us, (b)(4).Manufacturing location: (b)(4), manufacturing date: 24-sep-2013, part number: 04.034.558, 11mm ti cann tibial nail - ex w/prox bend 390mm, lot number: 7488601 (non-sterile), lot quantity: (b)(4), work order traveler met all inspection acceptance criteria.Inspection sheet, in-process acceptance sheet met all inspection acceptance criteria.Inspection sheet, inspect dimensional met all inspection acceptance criteria.Inspection sheet, final inspection met all inspection acceptance criteria.Packaging label log was reviewed and determined to be conforming.This lot met all dimensional, visual and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Component part(s) reviewed: raw material was not reviewed because the reported complaint condition of ¿removal due to possible infection¿ does not indicate breakage of the nail.Therefore, a dhr review of the raw material would not be pertinent to the reported complaint condition.This lot met all dimensional, visual and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|